Form 483

DX PRODUCTS LIMITED Form 483, 2017-12-07

FDA issued a Form 483 to DX PRODUCTS LIMITED on 2017-12-07 with 20 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health20 observations

DX PRODUCTS LIMITED · Wakefield, United Kingdom · Issued December 7, 2017

Overview

  • 20 public-safe observations are available for this inspection.
  • 10 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

7 Dec 2017
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Bonnie E Conley

7 Dec 2017
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Bonnie E Conley

7 Dec 2017
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Bonnie E Conley

7 Dec 2017
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Bonnie E Conley

7 Dec 2017
21 CFR 820.120

Lack of or inadequate procedures for labeling

Cited by Bonnie E Conley

Inspected site

DPDX PRODUCTS LIMITEDWakefield, United Kingdom

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.17Cited across public-safe Form 483 observations2x
21 CFR 820.100(a)Cited across public-safe Form 483 observations2x
21 CFR 820.120Cited across public-safe Form 483 observations2x
21 CFR 820.198(a)Cited across public-safe Form 483 observations2x
21 CFR 820.198(b)Cited across public-safe Form 483 observations2x
21 CFR 820.30(c)Cited across public-safe Form 483 observations2x
21 CFR 820.30(d)Cited across public-safe Form 483 observations2x
21 CFR 820.30(g)Cited across public-safe Form 483 observations2x
21 CFR 820.80(e)Cited across public-safe Form 483 observations2x
21 CFR 820.90(a)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 20 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere